Header Logo

Connection

MARGARET SPITZ to Male

Back to Details
This is a "connection" page, showing publications MARGARET SPITZ has written about Male.
MARGARET SPITZ
Connection Strength
1.648
Male
  1. Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer. J Thorac Oncol. 2018 10; 13(10):1483-1495.
    View in: PubMed
    Score: 0.025
  2. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer. J Thorac Oncol. 2016 Jan; 11(1):52-61.
    View in: PubMed
    Score: 0.021
  3. BRCA2-branching out too? J Natl Cancer Inst. 2015 May; 107(5).
    View in: PubMed
    Score: 0.020
  4. Exposure to pro-tobacco messages and smoking status among Mexican origin youth. J Immigr Minor Health. 2014 Jun; 16(3):385-93.
    View in: PubMed
    Score: 0.019
  5. Role of selected genetic variants in lung cancer risk in African Americans. J Thorac Oncol. 2013 Apr; 8(4):391-7.
    View in: PubMed
    Score: 0.017
  6. Sensation-seeking genes and physical activity in youth. Genes Brain Behav. 2013 Mar; 12(2):181-8.
    View in: PubMed
    Score: 0.017
  7. Multistage analysis of variants in the inflammation pathway and lung cancer risk in smokers. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1213-21.
    View in: PubMed
    Score: 0.016
  8. Experimenting with cigarettes and physical activity among Mexican origin youth: a cross sectional analysis of the interdependent associations among sensation seeking, acculturation, and gender. BMC Public Health. 2012 May 04; 12:332.
    View in: PubMed
    Score: 0.016
  9. Cigarette experimentation in Mexican origin youth: psychosocial and genetic determinants. Cancer Epidemiol Biomarkers Prev. 2012 Jan; 21(1):228-38.
    View in: PubMed
    Score: 0.016
  10. Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke. Cancer Discov. 2011 Oct; 1(5):420-9.
    View in: PubMed
    Score: 0.015
  11. Epidemiology--found in translation. Cancer Discov. 2011 Jun; 1(1):21-2.
    View in: PubMed
    Score: 0.015
  12. Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study. J Natl Cancer Inst. 2010 Aug 04; 102(15):1199-205.
    View in: PubMed
    Score: 0.014
  13. Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes. J Pain Symptom Manage. 2009 Dec; 38(6):894-902.
    View in: PubMed
    Score: 0.014
  14. Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy. Pharmacogenet Genomics. 2008 Nov; 18(11):955-65.
    View in: PubMed
    Score: 0.013
  15. Influence of subjective social status on the relationship between positive outcome expectations and experimentation with cigarettes. J Adolesc Health. 2009 Apr; 44(4):342-8.
    View in: PubMed
    Score: 0.013
  16. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst. 2008 Nov 05; 100(21):1552-6.
    View in: PubMed
    Score: 0.013
  17. Correlates of susceptibility to smoking among Mexican origin youth residing in Houston, Texas: a cross-sectional analysis. BMC Public Health. 2008 Sep 26; 8:337.
    View in: PubMed
    Score: 0.013
  18. Smoking-related genomic signatures in non-small cell lung cancer. Am J Respir Crit Care Med. 2008 Dec 01; 178(11):1164-72.
    View in: PubMed
    Score: 0.013
  19. An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila). 2008 Sep; 1(4):250-4.
    View in: PubMed
    Score: 0.013
  20. Development and validation of a lung cancer risk prediction model for African-Americans. Cancer Prev Res (Phila). 2008 Sep; 1(4):255-65.
    View in: PubMed
    Score: 0.013
  21. Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer. Mod Pathol. 2008 Aug; 21(8):950-60.
    View in: PubMed
    Score: 0.012
  22. Projecting individualized probabilities of developing bladder cancer in white individuals. J Clin Oncol. 2007 Nov 01; 25(31):4974-81.
    View in: PubMed
    Score: 0.012
  23. Aggregation of cancer among relatives of never-smoking lung cancer patients. Int J Cancer. 2007 Jul 01; 121(1):111-8.
    View in: PubMed
    Score: 0.012
  24. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res. 2007 Jul 01; 67(13):6520-7.
    View in: PubMed
    Score: 0.012
  25. Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk. Int J Cancer. 2007 Jun 15; 120(12):2687-95.
    View in: PubMed
    Score: 0.012
  26. A risk model for prediction of lung cancer. J Natl Cancer Inst. 2007 May 02; 99(9):715-26.
    View in: PubMed
    Score: 0.011
  27. Age-related differences in factors associated with smoking initiation. Cancer Causes Control. 2007 Aug; 18(6):635-44.
    View in: PubMed
    Score: 0.011
  28. A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma. Carcinogenesis. 2007 Jul; 28(7):1430-6.
    View in: PubMed
    Score: 0.011
  29. Joint effect of mutagen sensitivity and insulin-like growth factors in predicting the risk of developing secondary primary tumors and tumor recurrence in patients with head and neck cancer. Clin Cancer Res. 2006 Dec 01; 12(23):7194-201.
    View in: PubMed
    Score: 0.011
  30. Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res. 2006 Jun 15; 66(12):6449-56.
    View in: PubMed
    Score: 0.011
  31. Never smokers and lung cancer risk: a case-control study of epidemiological factors. Int J Cancer. 2006 Apr 01; 118(7):1798-804.
    View in: PubMed
    Score: 0.011
  32. An epidemiologic study of early onset lung cancer. Lung Cancer. 2006 May; 52(2):129-34.
    View in: PubMed
    Score: 0.011
  33. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet. 2006 Mar; 78(3):464-79.
    View in: PubMed
    Score: 0.011
  34. Combined effects of the p53 and p73 polymorphisms on lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2006 Jan; 15(1):158-61.
    View in: PubMed
    Score: 0.010
  35. Re: "Cancer mortality among US men and women with asthma and hay fever". Am J Epidemiol. 2006 Feb 15; 163(4):394-5; author reply 395-6.
    View in: PubMed
    Score: 0.010
  36. Dietary phytoestrogens and lung cancer risk. JAMA. 2005 Sep 28; 294(12):1493-504.
    View in: PubMed
    Score: 0.010
  37. Wood dust exposure and the association with lung cancer risk. Am J Ind Med. 2005 Apr; 47(4):349-57.
    View in: PubMed
    Score: 0.010
  38. Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy. Semin Oncol. 2005 Apr; 32(2 Suppl 3):S92-8.
    View in: PubMed
    Score: 0.010
  39. Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. Am J Epidemiol. 2005 Mar 01; 161(5):412-22.
    View in: PubMed
    Score: 0.010
  40. Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. Cancer Res. 2005 Jan 01; 65(1):349-57.
    View in: PubMed
    Score: 0.010
  41. Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):3988-95.
    View in: PubMed
    Score: 0.009
  42. Risk for smoking-related cancer among relatives of lung cancer patients. Cancer Res. 2003 Dec 01; 63(23):8531-5.
    View in: PubMed
    Score: 0.009
  43. Association between low dietary folate intake and suboptimal cellular DNA repair capacity. Cancer Epidemiol Biomarkers Prev. 2003 Oct; 12(10):963-9.
    View in: PubMed
    Score: 0.009
  44. Dietary folate intake and lung cancer risk in former smokers: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2003 Oct; 12(10):980-6.
    View in: PubMed
    Score: 0.009
  45. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003 Aug 20; 95(16):1211-8.
    View in: PubMed
    Score: 0.009
  46. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. Cancer Epidemiol Biomarkers Prev. 2002 Nov; 11(11):1413-8.
    View in: PubMed
    Score: 0.008
  47. Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors. Cancer Epidemiol Biomarkers Prev. 2002 Aug; 11(8):758-66.
    View in: PubMed
    Score: 0.008
  48. An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer. J Natl Cancer Inst. 2002 Jul 17; 94(14):1091-9.
    View in: PubMed
    Score: 0.008
  49. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. Cancer Res. 2002 May 15; 62(10):2813-8.
    View in: PubMed
    Score: 0.008
  50. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. J Natl Cancer Inst. 2002 May 01; 94(9):681-90.
    View in: PubMed
    Score: 0.008
  51. Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. J Clin Oncol. 2022 03 10; 40(8):876-883.
    View in: PubMed
    Score: 0.008
  52. The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans. Carcinogenesis. 2001 Jun; 22(6):923-8.
    View in: PubMed
    Score: 0.008
  53. Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry. Am J Hum Genet. 2021 04 01; 108(4):564-582.
    View in: PubMed
    Score: 0.007
  54. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 2001 Feb 15; 61(4):1354-7.
    View in: PubMed
    Score: 0.007
  55. Leptin and prostate cancer. Prostate. 2001 Jan 01; 46(1):62-7.
    View in: PubMed
    Score: 0.007
  56. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst. 2000 Nov 01; 92(21):1764-72.
    View in: PubMed
    Score: 0.007
  57. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1017-20.
    View in: PubMed
    Score: 0.007
  58. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1021-6.
    View in: PubMed
    Score: 0.007
  59. Epidemiologic determinants of clinically relevant prostate cancer. Int J Cancer. 2000 May 20; 89(3):259-64.
    View in: PubMed
    Score: 0.007
  60. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. J Natl Cancer Inst. 2000 May 03; 92(9):737-43.
    View in: PubMed
    Score: 0.007
  61. Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer. Br J Cancer. 1999 May; 80(3-4):453-7.
    View in: PubMed
    Score: 0.007
  62. Cross-Cancer Pleiotropic Associations with Lung Cancer Risk in African Americans. Cancer Epidemiol Biomarkers Prev. 2019 04; 28(4):715-723.
    View in: PubMed
    Score: 0.007
  63. Viewing images of alcohol use in PG-13-rated movies and alcohol initiation in Mexican-heritage youth. J Ethn Subst Abuse. 2020 Oct-Dec; 19(4):521-536.
    View in: PubMed
    Score: 0.006
  64. Case-control study of diet and prostate cancer in China. Cancer Causes Control. 1998 Dec; 9(6):545-52.
    View in: PubMed
    Score: 0.006
  65. Whole exome sequencing analysis in severe chronic obstructive pulmonary disease. Hum Mol Genet. 2018 11 01; 27(21):3801-3812.
    View in: PubMed
    Score: 0.006
  66. Chromosome 5 aberrations and genetic predisposition to lung cancer. Int J Cancer. 1998 Oct 23; 79(5):490-3.
    View in: PubMed
    Score: 0.006
  67. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst. 1998 Sep 16; 90(18):1393-9.
    View in: PubMed
    Score: 0.006
  68. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls. Cancer. 1998 Sep 15; 83(6):1118-27.
    View in: PubMed
    Score: 0.006
  69. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer. Cancer Res. 1998 Apr 15; 58(8):1605-8.
    View in: PubMed
    Score: 0.006
  70. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst. 1998 Mar 04; 90(5):358-63.
    View in: PubMed
    Score: 0.006
  71. Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract. J Natl Cancer Inst. 1998 Feb 04; 90(3):243-5.
    View in: PubMed
    Score: 0.006
  72. Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations. Cancer Epidemiol Biomarkers Prev. 1998 Jan; 7(1):13-8.
    View in: PubMed
    Score: 0.006
  73. Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk. Carcinogenesis. 1998 Jan; 19(1):93-8.
    View in: PubMed
    Score: 0.006
  74. Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers Prev. 1997 Sep; 6(9):687-92.
    View in: PubMed
    Score: 0.006
  75. Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer. Cancer Epidemiol Biomarkers Prev. 1997 Aug; 6(8):565-71.
    View in: PubMed
    Score: 0.006
  76. A clinical trial to evaluate the effect of vitamin C supplementation on in vitro mutagen sensitivity. The University of Texas M. D. Anderson Clinical Community Oncology Program Network. Cancer Epidemiol Biomarkers Prev. 1997 Jul; 6(7):537-42.
    View in: PubMed
    Score: 0.006
  77. Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nat Genet. 2017 Jul; 49(7):1126-1132.
    View in: PubMed
    Score: 0.006
  78. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis. 1997 May; 18(5):967-73.
    View in: PubMed
    Score: 0.006
  79. Lung carcinoma patients with a family history of cancer and lymphocyte primary chromosome 9 aberrations. Cancer. 1997 Apr 15; 79(8):1527-32.
    View in: PubMed
    Score: 0.006
  80. Case-control assessment of diet and lung cancer risk in African Americans and Mexican Americans. Nutr Cancer. 1997; 29(2):169-73.
    View in: PubMed
    Score: 0.006
  81. Reduced DNA repair capacity in lung cancer patients. Cancer Res. 1996 Sep 15; 56(18):4103-7.
    View in: PubMed
    Score: 0.005
  82. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res. 1996 Sep 01; 56(17):3975-9.
    View in: PubMed
    Score: 0.005
  83. Month-of-birth and incidence of acute lymphoblastic leukemia in children. Leuk Lymphoma. 1996 Sep; 23(1-2):85-92.
    View in: PubMed
    Score: 0.005
  84. Clinical and genetic investigation of a Brazilian family with Huntington's disease. Funct Neurol. 2016 Jul-Sep; 31(3):135-42.
    View in: PubMed
    Score: 0.005
  85. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome. Nat Commun. 2016 06 13; 7:11843.
    View in: PubMed
    Score: 0.005
  86. Gene by Environment Investigation of Incident Lung Cancer Risk in African-Americans. EBioMedicine. 2016 Feb; 4:153-61.
    View in: PubMed
    Score: 0.005
  87. Mutagen sensitivity as a marker of cancer susceptibility. J Cell Biochem Suppl. 1996; 25:80-4.
    View in: PubMed
    Score: 0.005
  88. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis. 1995 Sep; 16(9):2205-8.
    View in: PubMed
    Score: 0.005
  89. A case-control study of wood dust exposure, mutagen sensitivity, and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 1995 Sep; 4(6):583-8.
    View in: PubMed
    Score: 0.005
  90. Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer. J Natl Cancer Inst. 2015 Nov; 107(11).
    View in: PubMed
    Score: 0.005
  91. Demographic, psychosocial, and genetic risk associated with smokeless tobacco use among Mexican heritage youth. BMC Med Genet. 2015 Jun 26; 16:43.
    View in: PubMed
    Score: 0.005
  92. Lower lung cancer rates in Jewish smokers in Israel and the USA. Int J Cancer. 2015 Nov 01; 137(9):2155-62.
    View in: PubMed
    Score: 0.005
  93. Smoking Initiation Among Mexican Heritage Youth and the Roles of Family Cohesion and Conflict. J Adolesc Health. 2015 Jul; 57(1):24-30.
    View in: PubMed
    Score: 0.005
  94. Characterization of large structural genetic mosaicism in human autosomes. Am J Hum Genet. 2015 Mar 05; 96(3):487-97.
    View in: PubMed
    Score: 0.005
  95. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev. 1995 Mar; 4(2):99-103.
    View in: PubMed
    Score: 0.005
  96. A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases. Cancer Res. 1995 Feb 01; 55(3):557-61.
    View in: PubMed
    Score: 0.005
  97. A recurrent mutation in PARK2 is associated with familial lung cancer. Am J Hum Genet. 2015 Feb 05; 96(2):301-8.
    View in: PubMed
    Score: 0.005
  98. Informed genome-wide association analysis with family history as a secondary phenotype identifies novel loci of lung cancer. Genet Epidemiol. 2015 Mar; 39(3):197-206.
    View in: PubMed
    Score: 0.005
  99. Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans. J Natl Cancer Inst Monogr. 1995; (18):29-33.
    View in: PubMed
    Score: 0.005
  100. CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations. Carcinogenesis. 2015 Jan; 36(1):99-103.
    View in: PubMed
    Score: 0.005
  101. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J Natl Cancer Inst. 1994 Nov 16; 86(22):1681-4.
    View in: PubMed
    Score: 0.005
  102. Education and lung cancer among never smokers. Epidemiology. 2014 Nov; 25(6):934-5.
    View in: PubMed
    Score: 0.005
  103. The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction model. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2462-70.
    View in: PubMed
    Score: 0.005
  104. A risk prediction model for smoking experimentation in Mexican American youth. Cancer Epidemiol Biomarkers Prev. 2014 Oct; 23(10):2165-74.
    View in: PubMed
    Score: 0.005
  105. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet. 2014 Dec 15; 23(24):6616-33.
    View in: PubMed
    Score: 0.005
  106. Wnt signaling pathway pharmacogenetics in non-small cell lung cancer. Pharmacogenomics J. 2014 Dec; 14(6):509-22.
    View in: PubMed
    Score: 0.005
  107. A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans. Carcinogenesis. 1994 Jun; 15(6):1121-4.
    View in: PubMed
    Score: 0.005
  108. Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapy. Clin Pharmacol Ther. 2014 Sep; 96(3):360-369.
    View in: PubMed
    Score: 0.005
  109. Distinct loci in the CHRNA5/CHRNA3/CHRNB4 gene cluster are associated with onset of regular smoking. Genet Epidemiol. 2013 Dec; 37(8):846-59.
    View in: PubMed
    Score: 0.004
  110. Self-reported prior lung diseases as risk factors for non-small cell lung cancer in Mexican Americans. J Immigr Minor Health. 2013 Oct; 15(5):910-7.
    View in: PubMed
    Score: 0.004
  111. Cancer risk and early detection assessment. Semin Oncol Nurs. 1993 Aug; 9(3):188-97.
    View in: PubMed
    Score: 0.004
  112. Symptom clusters of pain, depressed mood, and fatigue in lung cancer: assessing the role of cytokine genes. Support Care Cancer. 2013 Nov; 21(11):3117-25.
    View in: PubMed
    Score: 0.004
  113. Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug; 2(4):329-33.
    View in: PubMed
    Score: 0.004
  114. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog. 2013 Nov; 52 Suppl 1:E139-47.
    View in: PubMed
    Score: 0.004
  115. Heme-related gene expression signatures of meat intakes in lung cancer tissues. Mol Carcinog. 2014 Jul; 53(7):548-56.
    View in: PubMed
    Score: 0.004
  116. The associations of body image, anxiety, and smoking among Mexican-origin youth. J Adolesc Health. 2013 Aug; 53(2):209-14.
    View in: PubMed
    Score: 0.004
  117. Pilot study of CYP2B6 genetic variation to explore the contribution of nitrosamine activation to lung carcinogenesis. Int J Mol Sci. 2013 Apr 16; 14(4):8381-92.
    View in: PubMed
    Score: 0.004
  118. Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls. Hum Genet. 2013 05; 132(5):579-89.
    View in: PubMed
    Score: 0.004
  119. Investigating multiple candidate genes and nutrients in the folate metabolism pathway to detect genetic and nutritional risk factors for lung cancer. PLoS One. 2013; 8(1):e53475.
    View in: PubMed
    Score: 0.004
  120. Cigarette experimentation and the population attributable fraction for associated genetic and non-genetic risk factors. PLoS One. 2013; 8(1):e53868.
    View in: PubMed
    Score: 0.004
  121. Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans. Cancer Epidemiol Biomarkers Prev. 2013 Feb; 22(2):251-60.
    View in: PubMed
    Score: 0.004
  122. Use of the cytokinesis-blocked micronucleus assay to detect gender differences and genetic instability in a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):135-45.
    View in: PubMed
    Score: 0.004
  123. Genetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patients. J Pain Symptom Manage. 2013 Aug; 46(2):161-72.
    View in: PubMed
    Score: 0.004
  124. Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans. Oncotarget. 2012 Nov; 3(11):1428-38.
    View in: PubMed
    Score: 0.004
  125. Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer. Cancer Res. 2013 Jan 01; 73(1):256-64.
    View in: PubMed
    Score: 0.004
  126. Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study. Clin Cancer Res. 2012 Nov 01; 18(21):5983-91.
    View in: PubMed
    Score: 0.004
  127. AACR Cancer Progress Report 2012. Clin Cancer Res. 2012 Nov 01; 18(21 Suppl):S1-100.
    View in: PubMed
    Score: 0.004
  128. Eliminating second-hand smoke from Mexican-American households: outcomes from Project Clean Air-Safe Air (CASA). Addict Behav. 2013 Jan; 38(1):1485-92.
    View in: PubMed
    Score: 0.004
  129. Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers. Arch Gen Psychiatry. 2012 Aug; 69(8):854-60.
    View in: PubMed
    Score: 0.004
  130. Chapter 11: Rice-MD Anderson lung cancer model. Risk Anal. 2012 Jul; 32 Suppl 1:S142-50.
    View in: PubMed
    Score: 0.004
  131. Genome-wide gene-environment interaction analysis for asbestos exposure in lung cancer susceptibility. Carcinogenesis. 2012 Aug; 33(8):1531-7.
    View in: PubMed
    Score: 0.004
  132. Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet. 2012 May 06; 44(6):651-8.
    View in: PubMed
    Score: 0.004
  133. Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25. Genet Epidemiol. 2012 May; 36(4):340-51.
    View in: PubMed
    Score: 0.004
  134. Body mass index and risk of lung cancer among never, former, and current smokers. J Natl Cancer Inst. 2012 May 16; 104(10):778-89.
    View in: PubMed
    Score: 0.004
  135. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer. 2012 Sep; 48(13):1957-68.
    View in: PubMed
    Score: 0.004
  136. Comparison of pathway analysis approaches using lung cancer GWAS data sets. PLoS One. 2012; 7(2):e31816.
    View in: PubMed
    Score: 0.004
  137. Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. Am J Epidemiol. 2012 May 15; 175(10):1013-20.
    View in: PubMed
    Score: 0.004
  138. Genetic and environmental interactions as risks for aerodigestive cancers. Adv Exp Med Biol. 1992; 320:31-4.
    View in: PubMed
    Score: 0.004
  139. Familial patterns of prostate cancer: a case-control analysis. J Urol. 1991 Nov; 146(5):1305-7.
    View in: PubMed
    Score: 0.004
  140. A case-control study of a sex-specific association between a 15q25 variant and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2603-9.
    View in: PubMed
    Score: 0.004
  141. Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer. Carcinogenesis. 2011 Dec; 32(12):1867-71.
    View in: PubMed
    Score: 0.004
  142. DNA repair capacity in peripheral lymphocytes predicts survival of patients with non-small-cell lung cancer treated with first-line platinum-based chemotherapy. J Clin Oncol. 2011 Nov 01; 29(31):4121-8.
    View in: PubMed
    Score: 0.004
  143. Activating enhancer-binding protein-2? nucleolar localization predicts poor survival after stage I non-small cell lung cancer resection. Ann Thorac Surg. 2011 Sep; 92(3):1044-50.
    View in: PubMed
    Score: 0.004
  144. Gender differences in sociodemographic and behavioral influences of physical activity in Mexican-origin adolescents. J Phys Act Health. 2012 Aug; 9(6):829-39.
    View in: PubMed
    Score: 0.004
  145. Dietary patterns affect lung cancer risk in never smokers. Nutr Cancer. 2011; 63(6):842-9.
    View in: PubMed
    Score: 0.004
  146. Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis. 2011 Oct; 32(10):1493-9.
    View in: PubMed
    Score: 0.004
  147. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. J Natl Cancer Inst. 2011 Sep 07; 103(17):1342-6.
    View in: PubMed
    Score: 0.004
  148. Association of smoking with tumor size at diagnosis in non-small cell lung cancer. Lung Cancer. 2011 Dec; 74(3):378-83.
    View in: PubMed
    Score: 0.004
  149. Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer. Carcinogenesis. 2011 Jul; 32(7):1050-6.
    View in: PubMed
    Score: 0.004
  150. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J Natl Cancer Inst. 2011 May 18; 103(10):817-25.
    View in: PubMed
    Score: 0.004
  151. A smoking-based carcinogenesis model for lung cancer risk prediction. Int J Cancer. 2011 Oct 15; 129(8):1907-13.
    View in: PubMed
    Score: 0.004
  152. An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPs. DNA Repair (Amst). 2011 Apr 03; 10(4):398-407.
    View in: PubMed
    Score: 0.004
  153. Association of a novel functional promoter variant (rs2075533 C>T) in the apoptosis gene TNFSF8 with risk of lung cancer--a finding from Texas lung cancer genome-wide association study. Carcinogenesis. 2011 Apr; 32(4):507-15.
    View in: PubMed
    Score: 0.004
  154. Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients. Cancer Prev Res (Phila). 2011 Feb; 4(2):185-93.
    View in: PubMed
    Score: 0.004
  155. Variants in folate pathway genes as modulators of genetic instability and lung cancer risk. Genes Chromosomes Cancer. 2011 Jan; 50(1):1-12.
    View in: PubMed
    Score: 0.004
  156. Sensation seeking, risk behaviors, and alcohol consumption among Mexican origin youth. J Adolesc Health. 2011 Jan; 48(1):65-72.
    View in: PubMed
    Score: 0.004
  157. Admixture mapping of lung cancer in 1812 African-Americans. Carcinogenesis. 2011 Mar; 32(3):312-7.
    View in: PubMed
    Score: 0.004
  158. Salivary gland cancer. A case-control investigation of risk factors. Arch Otolaryngol Head Neck Surg. 1990 Oct; 116(10):1163-6.
    View in: PubMed
    Score: 0.004
  159. Leukemia and cigarette smoking. Cancer Causes Control. 1990 Sep; 1(2):195-6.
    View in: PubMed
    Score: 0.004
  160. Assessing environmental and occupational risk factors for lung cancer in Mexican-Americans. Cancer Causes Control. 2010 Dec; 21(12):2157-64.
    View in: PubMed
    Score: 0.004
  161. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One. 2010 Aug 25; 5(8):e12402.
    View in: PubMed
    Score: 0.004
  162. Rapid method for determination of DNA repair capacity in human peripheral blood lymphocytes amongst smokers. BMC Cancer. 2010 Aug 18; 10:439.
    View in: PubMed
    Score: 0.004
  163. Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet. 2010 Aug 05; 6(8).
    View in: PubMed
    Score: 0.004
  164. Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study. Clin Cancer Res. 2010 Aug 01; 16(15):3976-87.
    View in: PubMed
    Score: 0.004
  165. Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk. Cancer. 2010 Jul 15; 116(14):3458-62.
    View in: PubMed
    Score: 0.004
  166. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst. 2010 Jul 07; 102(13):959-71.
    View in: PubMed
    Score: 0.004
  167. A functional variant of tandem repeats in human telomerase gene was associated with survival of patients with early stages of non-small cell lung cancer. Clin Cancer Res. 2010 Jul 15; 16(14):3779-85.
    View in: PubMed
    Score: 0.004
  168. PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy. Lung Cancer. 2011 Jan; 71(1):82-8.
    View in: PubMed
    Score: 0.004
  169. Salivary gland cancer and risk of subsequent skin cancer. Head Neck. 1990 May-Jun; 12(3):254-6.
    View in: PubMed
    Score: 0.004
  170. Early cancer detection: update for primary-care physicians. Tex Med. 1990 Apr; 86(4):44-7.
    View in: PubMed
    Score: 0.004
  171. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol. 2010 Apr; 11(4):321-30.
    View in: PubMed
    Score: 0.003
  172. Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res. 2010 Jan 15; 16(2):764-74.
    View in: PubMed
    Score: 0.003
  173. Cigarette smoking patterns in patients after treatment of upper aerodigestive tract cancers. J Cancer Educ. 1990; 5(2):109-13.
    View in: PubMed
    Score: 0.003
  174. Cigarette smoking patterns of cancer patients. Prog Clin Biol Res. 1990; 339:73-82.
    View in: PubMed
    Score: 0.003
  175. Childhood nervous system tumours: an assessment of risk associated with paternal occupations involving use, repair or manufacture of electrical and electronic equipment. Int J Epidemiol. 1989 Dec; 18(4):756-62.
    View in: PubMed
    Score: 0.003
  176. Exposure to smoking imagery in the movies and experimenting with cigarettes among Mexican heritage youth. Cancer Epidemiol Biomarkers Prev. 2009 Dec; 18(12):3435-43.
    View in: PubMed
    Score: 0.003
  177. Cognitive susceptibility to smoking: Two paths to experimenting among Mexican origin youth. Cancer Epidemiol Biomarkers Prev. 2009 Dec; 18(12):3459-67.
    View in: PubMed
    Score: 0.003
  178. Role of inflammation gene polymorphisms on pain severity in lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2636-42.
    View in: PubMed
    Score: 0.003
  179. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res. 1989 Aug 15; 49(16):4626-8.
    View in: PubMed
    Score: 0.003
  180. Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res. 2009 Aug 15; 69(16):6633-41.
    View in: PubMed
    Score: 0.003
  181. Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants. Cancer Prev Res (Phila). 2009 Jul; 2(7):617-24.
    View in: PubMed
    Score: 0.003
  182. Maternal current smoking: concordance between adolescent proxy and mother's self-report. Nicotine Tob Res. 2009 Aug; 11(8):1016-9.
    View in: PubMed
    Score: 0.003
  183. Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology. 2009 May; 49(5):1563-70.
    View in: PubMed
    Score: 0.003
  184. Encouraging trends in lung cancer mortality in Texas, 1970 to 1986. Tex Med. 1989 Mar; 85(3):42-4.
    View in: PubMed
    Score: 0.003
  185. The implementation and applications of a cancer patient risk evaluation questionnaire. Prog Clin Biol Res. 1989; 293:263-70.
    View in: PubMed
    Score: 0.003
  186. Sociodemographic characteristics, health beliefs, and the accuracy of cancer knowledge. J Cancer Educ. 2009; 24(1):58-64.
    View in: PubMed
    Score: 0.003
  187. Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions. Cancer. 2008 Nov 01; 113(9):2488-95.
    View in: PubMed
    Score: 0.003
  188. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):3081-9.
    View in: PubMed
    Score: 0.003
  189. The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):3262-7.
    View in: PubMed
    Score: 0.003
  190. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008 Oct 23; 455(7216):1069-75.
    View in: PubMed
    Score: 0.003
  191. Ethnic patterns of thyroid cancer incidence in the United States, 1973-1981. Int J Cancer. 1988 Oct 15; 42(4):549-53.
    View in: PubMed
    Score: 0.003
  192. Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study. Int J Cancer. 2008 Oct 15; 123(8):1883-91.
    View in: PubMed
    Score: 0.003
  193. Dietary alpha-, beta-, gamma- and delta-tocopherols in lung cancer risk. Int J Cancer. 2008 Sep 01; 123(5):1173-80.
    View in: PubMed
    Score: 0.003
  194. 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC). J Thorac Oncol. 2008 Sep; 3(9):979-84.
    View in: PubMed
    Score: 0.003
  195. Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst. 2008 Aug 06; 100(15):1104-12.
    View in: PubMed
    Score: 0.003
  196. Trends in prevalence of prognostic factors and survival in lung cancer patients from 1985 to 2004 at a tertiary care center. Cancer Detect Prev. 2008; 32(2):101-8.
    View in: PubMed
    Score: 0.003
  197. The development of a comprehensive, institution-based patient risk evaluation program: II. Validity and reliability of questionnaire data. Am J Prev Med. 1988 Jul-Aug; 4(4):188-93.
    View in: PubMed
    Score: 0.003
  198. Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions. Eur J Cancer. 2008 Jul; 44(11):1603-11.
    View in: PubMed
    Score: 0.003
  199. Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer. Cancer. 2008 Jun 15; 112(12):2756-64.
    View in: PubMed
    Score: 0.003
  200. DNA repair capacity and lung cancer risk in never smokers. Cancer Epidemiol Biomarkers Prev. 2008 Jun; 17(6):1322-8.
    View in: PubMed
    Score: 0.003
  201. Cytokinesis-blocked micronucleus cytome assay biomarkers identify lung cancer cases amongst smokers. Cancer Epidemiol Biomarkers Prev. 2008 May; 17(5):1111-9.
    View in: PubMed
    Score: 0.003
  202. Incidence of salivary gland cancer in the United States relative to ultraviolet radiation exposure. Head Neck Surg. 1988 May-Jun; 10(5):305-8.
    View in: PubMed
    Score: 0.003
  203. Dietary magnesium and DNA repair capacity as risk factors for lung cancer. Carcinogenesis. 2008 May; 29(5):949-56.
    View in: PubMed
    Score: 0.003
  204. Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancer. Br J Cancer. 2008 May 20; 98(10):1716-22.
    View in: PubMed
    Score: 0.003
  205. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 2008 May; 40(5):616-22.
    View in: PubMed
    Score: 0.003
  206. Profiles of cigarette smoking among patients in a cancer center. J Cancer Educ. 1988; 3(4):265-71.
    View in: PubMed
    Score: 0.003
  207. Squamous cell carcinoma of the upper aerodigestive tract. A case comparison analysis. Cancer. 1988 Jan 01; 61(1):203-8.
    View in: PubMed
    Score: 0.003
  208. Joint effects of dietary trace metals and DNA repair capacity in lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2007 Dec; 16(12):2756-62.
    View in: PubMed
    Score: 0.003
  209. ATM sequence variants associate with susceptibility to non-small cell lung cancer. Int J Cancer. 2007 Nov 15; 121(10):2254-9.
    View in: PubMed
    Score: 0.003
  210. Genetic variants in cell cycle control pathway confer susceptibility to lung cancer. Clin Cancer Res. 2007 Oct 01; 13(19):5974-81.
    View in: PubMed
    Score: 0.003
  211. Maternal BMI and country of birth as indicators of childhood obesity in children of Mexican origin. Obesity (Silver Spring). 2007 Oct; 15(10):2512-9.
    View in: PubMed
    Score: 0.003
  212. Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: genotype-phenotype correlation. Cancer Epidemiol Biomarkers Prev. 2007 Oct; 16(10):2065-71.
    View in: PubMed
    Score: 0.003
  213. Seizure 6-like (SEZ6L) gene and risk for lung cancer. Cancer Res. 2007 Sep 01; 67(17):8406-11.
    View in: PubMed
    Score: 0.003
  214. Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck. Cancer. 2007 Aug 15; 110(4):867-75.
    View in: PubMed
    Score: 0.003
  215. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2007 Aug; 16(8):1633-8.
    View in: PubMed
    Score: 0.003
  216. Deficient G2-M and S checkpoints are associated with increased lung cancer risk: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2007 Jul; 16(7):1517-22.
    View in: PubMed
    Score: 0.003
  217. Nucleotide excision repair pathway genes and oral premalignant lesions. Clin Cancer Res. 2007 Jun 15; 13(12):3753-8.
    View in: PubMed
    Score: 0.003
  218. Polymorphisms of cytosolic serine hydroxymethyltransferase and risk of lung cancer: a case-control analysis. Lung Cancer. 2007 Aug; 57(2):143-51.
    View in: PubMed
    Score: 0.003
  219. Birthplace, years of residence in the United States, and obesity among Mexican-American adults. Obesity (Silver Spring). 2007 Apr; 15(4):1043-52.
    View in: PubMed
    Score: 0.003
  220. Irradiation-induced telomerase activity and the risk of lung cancer: a pilot case-control study. Cancer. 2007 Mar 15; 109(6):1157-63.
    View in: PubMed
    Score: 0.003
  221. Dietary zinc, copper and selenium, and risk of lung cancer. Int J Cancer. 2007 Mar 01; 120(5):1108-15.
    View in: PubMed
    Score: 0.003
  222. Differential induction in telomerase activity among bladder cancer patients and controls on gamma-radiation. Cancer Epidemiol Biomarkers Prev. 2007 Mar; 16(3):606-9.
    View in: PubMed
    Score: 0.003
  223. Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer. Clin Cancer Res. 2006 Dec 15; 12(24):7329-38.
    View in: PubMed
    Score: 0.003
  224. Association of genetic variants of O6-methylguanine-DNA methyltransferase with risk of lung cancer in non-Hispanic Whites. Cancer Epidemiol Biomarkers Prev. 2006 Dec; 15(12):2364-9.
    View in: PubMed
    Score: 0.003
  225. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. Carcinogenesis. 2007 May; 28(5):988-94.
    View in: PubMed
    Score: 0.003
  226. Incidence and descriptive features of testicular cancer among United States whites, blacks, and Hispanics, 1973-1982. Cancer. 1986 Oct 15; 58(8):1785-90.
    View in: PubMed
    Score: 0.003
  227. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer. Clin Cancer Res. 2006 Oct 01; 12(19):5720-5.
    View in: PubMed
    Score: 0.003
  228. Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis. Cancer Epidemiol Biomarkers Prev. 2006 Oct; 15(10):1935-40.
    View in: PubMed
    Score: 0.003
  229. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2006 Sep 15; 12(18):5596-602.
    View in: PubMed
    Score: 0.003
  230. E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer. Clin Genet. 2006 Sep; 70(3):240-5.
    View in: PubMed
    Score: 0.003
  231. Bladder cancer risk as modified by family history and smoking. Cancer. 2006 Aug 15; 107(4):705-11.
    View in: PubMed
    Score: 0.003
  232. Human sensitivity to PhIP: a novel marker for prostate cancer risk. Mutat Res. 2006 Oct 10; 601(1-2):1-10.
    View in: PubMed
    Score: 0.003
  233. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer. Cancer. 2006 Jun 15; 106(12):2636-44.
    View in: PubMed
    Score: 0.003
  234. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res. 2006 Jun 15; 12(12):3661-97.
    View in: PubMed
    Score: 0.003
  235. MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis. Carcinogenesis. 2006 Oct; 27(10):2028-33.
    View in: PubMed
    Score: 0.003
  236. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis. 2006 Oct; 27(10):2034-7.
    View in: PubMed
    Score: 0.003
  237. Sex ratio of offspring of patients with prostatic cancer. CMAJ. 1986 Jan 15; 134(2):104-5.
    View in: PubMed
    Score: 0.003
  238. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. Cancer. 2006 Jan 15; 106(2):441-7.
    View in: PubMed
    Score: 0.003
  239. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst. 2005 Dec 21; 97(24):1822-31.
    View in: PubMed
    Score: 0.003
  240. Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: a case-control analysis. Pharmacogenet Genomics. 2005 Aug; 15(8):547-55.
    View in: PubMed
    Score: 0.003
  241. Polymorphisms and haplotypes of serine hydroxymethyltransferase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Pharmacogenet Genomics. 2005 Aug; 15(8):557-64.
    View in: PubMed
    Score: 0.003
  242. Increased plasma levels of angiogenin and the risk of bladder carcinoma: from initiation ot recurrence. Cancer. 2005 Jul 01; 104(1):30-5.
    View in: PubMed
    Score: 0.003
  243. Effects of 9-cis-retinoic acid on the insulin-like growth factor axis in former smokers. J Clin Oncol. 2005 Jul 01; 23(19):4439-49.
    View in: PubMed
    Score: 0.003
  244. A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1832-6.
    View in: PubMed
    Score: 0.003
  245. Effects of nativity, age at migration, and acculturation on smoking among adult Houston residents of Mexican descent. Am J Public Health. 2005 Jun; 95(6):1043-9.
    View in: PubMed
    Score: 0.003
  246. Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms. Cancer Epidemiol Biomarkers Prev. 2005 Jun; 14(6):1477-84.
    View in: PubMed
    Score: 0.003
  247. Neuroblastoma and paternal occupation. A case-control analysis. Am J Epidemiol. 1985 Jun; 121(6):924-9.
    View in: PubMed
    Score: 0.003
  248. Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer. 2005 May 20; 115(1):131-6.
    View in: PubMed
    Score: 0.003
  249. Inflammatory gene polymorphisms influence risk of postoperative morbidity after lung resection. Ann Thorac Surg. 2005 May; 79(5):1704-10.
    View in: PubMed
    Score: 0.002
  250. Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1188-93.
    View in: PubMed
    Score: 0.002
  251. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy. Clin Cancer Res. 2005 Apr 15; 11(8):2894-8.
    View in: PubMed
    Score: 0.002
  252. An association between a NQO1 genetic polymorphism and risk of lung cancer. Mutat Res. 2005 Apr 04; 582(1-2):71-8.
    View in: PubMed
    Score: 0.002
  253. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):878-84.
    View in: PubMed
    Score: 0.002
  254. CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):1034-6.
    View in: PubMed
    Score: 0.002
  255. Multiple primary cancer risk in patients with major salivary gland carcinoma. Ann Otol Rhinol Laryngol. 1985 Mar-Apr; 94(2 Pt 1):129-32.
    View in: PubMed
    Score: 0.002
  256. Chromosomal instability in peripheral blood lymphocytes and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2005 Mar; 14(3):748-52.
    View in: PubMed
    Score: 0.002
  257. Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer. Pharmacogenet Genomics. 2005 Mar; 15(3):159-65.
    View in: PubMed
    Score: 0.002
  258. Relationship between plasma carotenoids and prostate cancer. Nutr Cancer. 2005; 53(2):127-34.
    View in: PubMed
    Score: 0.002
  259. Case-control analysis of dietary folate and risk of bladder cancer. Nutr Cancer. 2005; 53(2):144-51.
    View in: PubMed
    Score: 0.002
  260. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer. Genes Chromosomes Cancer. 2004 Dec; 41(4):379-89.
    View in: PubMed
    Score: 0.002
  261. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer. Genes Chromosomes Cancer. 2004 Dec; 41(4):330-8.
    View in: PubMed
    Score: 0.002
  262. Dietary carotenoids and genetic instability modify bladder cancer risk. J Nutr. 2004 Dec; 134(12):3362-9.
    View in: PubMed
    Score: 0.002
  263. Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2004 Dec 01; 10(23):7903-10.
    View in: PubMed
    Score: 0.002
  264. Complex segregation analysis reveals a multigene model for lung cancer. Hum Genet. 2005 Jan; 116(1-2):121-7.
    View in: PubMed
    Score: 0.002
  265. Risk factors for major salivary gland carcinoma. A case-comparison study. Cancer. 1984 Nov 01; 54(9):1854-9.
    View in: PubMed
    Score: 0.002
  266. p73 G4C14-to-A4T14 polymorphism and risk of lung cancer. Cancer Res. 2004 Oct 01; 64(19):6863-6.
    View in: PubMed
    Score: 0.002
  267. Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients. Prostate. 2004 Sep 01; 60(4):343-51.
    View in: PubMed
    Score: 0.002
  268. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):3996-4002.
    View in: PubMed
    Score: 0.002
  269. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2004 Oct; 25(10):1911-6.
    View in: PubMed
    Score: 0.002
  270. No Association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):1081-3.
    View in: PubMed
    Score: 0.002
  271. Methyl-CpG-binding domain 2: a protective role in bladder carcinoma. Cancer. 2004 May 01; 100(9):1853-8.
    View in: PubMed
    Score: 0.002
  272. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis. 2004 Sep; 25(9):1639-47.
    View in: PubMed
    Score: 0.002
  273. Training future pharmacists at a minority educational institution: evaluation of the Rx for change tobacco cessation training program. Cancer Epidemiol Biomarkers Prev. 2004 Mar; 13(3):477-81.
    View in: PubMed
    Score: 0.002
  274. Major salivary gland carcinoma. Descriptive epidemiology and survival of 498 patients. Arch Otolaryngol. 1984 Jan; 110(1):45-9.
    View in: PubMed
    Score: 0.002
  275. p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma. J Invest Dermatol. 2003 Dec; 121(6):1510-4.
    View in: PubMed
    Score: 0.002
  276. Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int J Cancer. 2003 Oct 20; 107(1):84-8.
    View in: PubMed
    Score: 0.002
  277. XRCC3 genetic polymorphism, smoking, and lung carcinoma risk in minority populations. Cancer. 2003 Oct 15; 98(8):1701-6.
    View in: PubMed
    Score: 0.002
  278. Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer. Lung Cancer. 2003 Oct; 42(1):1-8.
    View in: PubMed
    Score: 0.002
  279. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst). 2003 Aug 12; 2(8):901-8.
    View in: PubMed
    Score: 0.002
  280. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res. 2003 Jul; 9(7):2620-6.
    View in: PubMed
    Score: 0.002
  281. An association between NQO1 genetic polymorphism and risk of bladder cancer. Mutat Res. 2003 Apr 20; 536(1-2):131-7.
    View in: PubMed
    Score: 0.002
  282. Genetic instability in bladder cancer assessed by the comet assay. J Natl Cancer Inst. 2003 Apr 02; 95(7):540-7.
    View in: PubMed
    Score: 0.002
  283. Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study. Lung Cancer. 2003 Apr; 40(1):25-32.
    View in: PubMed
    Score: 0.002
  284. Death receptor 4 and bladder cancer risk. Cancer Res. 2003 Mar 15; 63(6):1157-9.
    View in: PubMed
    Score: 0.002
  285. Overexpression of hMTH in peripheral lymphocytes and risk of prostate cancer: a case-control analysis. Mol Carcinog. 2003 Mar; 36(3):123-9.
    View in: PubMed
    Score: 0.002
  286. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst. 2003 Feb 19; 95(4):308-15.
    View in: PubMed
    Score: 0.002
  287. Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol. 2003 Feb; 169(2):714-7.
    View in: PubMed
    Score: 0.002
  288. A case-control analysis of lymphocytic chromosome 9 aberrations in lung cancer. Int J Cancer. 2002 Dec 10; 102(5):536-40.
    View in: PubMed
    Score: 0.002
  289. Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat Res. 2002 Nov 30; 509(1-2):165-74.
    View in: PubMed
    Score: 0.002
  290. DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev. 2002 Oct; 11(10 Pt 1):1142-3.
    View in: PubMed
    Score: 0.002
  291. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett. 2002 Sep 26; 183(2):123-30.
    View in: PubMed
    Score: 0.002
  292. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res. 2002 Sep 01; 62(17):4992-5.
    View in: PubMed
    Score: 0.002
  293. DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2002 Sep; 128(9):1084-8.
    View in: PubMed
    Score: 0.002
  294. BPDE-induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk. Cancer. 2002 Aug 01; 95(3):563-8.
    View in: PubMed
    Score: 0.002
  295. A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung Cancer. 2002 Jul; 37(1):35-40.
    View in: PubMed
    Score: 0.002
  296. Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Epidemiol Biomarkers Prev. 2002 Jul; 11(7):640-5.
    View in: PubMed
    Score: 0.002
  297. XPD/ERCC2 EXON 8 Polymorphisms: rarity and lack of significance in risk of squamous cell carcinoma of the head and neck. Oral Oncol. 2002 Jul; 38(5):475-7.
    View in: PubMed
    Score: 0.002
  298. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. Am J Ind Med. 2002 Jul; 42(1):29-37.
    View in: PubMed
    Score: 0.002
  299. Genetic instability of specific chromosomes associated with a family history of cancer. Cancer Genet Cytogenet. 2002 Jul 01; 136(1):73-7.
    View in: PubMed
    Score: 0.002
  300. A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer. 2002 Jun 20; 99(6):869-72.
    View in: PubMed
    Score: 0.002
  301. Polymorphism of DNA ligase I and risk of lung cancer--a case-control analysis. Lung Cancer. 2002 Jun; 36(3):243-7.
    View in: PubMed
    Score: 0.002
  302. Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis. Lung Cancer. 2002 Feb; 35(2):137-42.
    View in: PubMed
    Score: 0.002
  303. Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer. 2002 Jan 15; 94(2):393-7.
    View in: PubMed
    Score: 0.002
  304. Polymorphic hCHK2/hCds1 codon 84 allele and risk of squamous cell carcinoma of the head and neck--a case-control analysis. Carcinogenesis. 2001 Dec; 22(12):2005-8.
    View in: PubMed
    Score: 0.002
  305. Evaluation of Mexican American migrant farmworker work practices and organochlorine pesticide metabolites. Am J Ind Med. 2001 Nov; 40(5):554-60.
    View in: PubMed
    Score: 0.002
  306. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res. 2001 Nov 01; 61(21):7825-9.
    View in: PubMed
    Score: 0.002
  307. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer. 2001 Sep 20; 95(5):332-6.
    View in: PubMed
    Score: 0.002
  308. Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Causes Control. 2001 Sep; 12(7):627-33.
    View in: PubMed
    Score: 0.002
  309. In vitro BPDE-induced DNA adducts in peripheral lymphocytes as a risk factor for squamous cell carcinoma of the head and neck. Int J Cancer. 2001 Aug 01; 93(3):436-40.
    View in: PubMed
    Score: 0.002
  310. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis. 2001 Aug; 22(8):1195-9.
    View in: PubMed
    Score: 0.002
  311. Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: a case-control study. Prostate. 2001 Jun 01; 47(4):269-75.
    View in: PubMed
    Score: 0.002
  312. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q. Oncogene. 2001 Apr 26; 20(18):2273-80.
    View in: PubMed
    Score: 0.002
  313. An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Res. 2001 Apr 15; 61(8):3321-5.
    View in: PubMed
    Score: 0.002
  314. Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):397-401.
    View in: PubMed
    Score: 0.002
  315. Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and pharynx. Cancer Epidemiol Biomarkers Prev. 2001 Mar; 10(3):273-5.
    View in: PubMed
    Score: 0.002
  316. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis. Cancer Res. 2001 Feb 15; 61(4):1445-50.
    View in: PubMed
    Score: 0.002
  317. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis. 2000 Dec; 21(12):2219-23.
    View in: PubMed
    Score: 0.002
  318. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer. 2000 Nov 15; 88(4):601-6.
    View in: PubMed
    Score: 0.002
  319. Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1043-9.
    View in: PubMed
    Score: 0.002
  320. Gamma-radiation-induced single cell DNA damage as a measure of susceptibility to lung cancer: a preliminary report. Int J Oncol. 2000 Aug; 17(2):399-404.
    View in: PubMed
    Score: 0.002
  321. Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. Carcinogenesis. 2000 Aug; 21(8):1527-30.
    View in: PubMed
    Score: 0.002
  322. Gender difference in smoking effect on chromosome sensitivity to gamma radiation in a healthy population. Radiat Res. 2000 Jul; 154(1):20-7.
    View in: PubMed
    Score: 0.002
  323. Statistical models for analysis of cytogenetic biomarkers. J Investig Med. 2000 Jul; 48(4):281-6.
    View in: PubMed
    Score: 0.002
  324. Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis. 2000 Jun; 21(6):1163-6.
    View in: PubMed
    Score: 0.002
  325. Adenocarcinoma of the lung in young patients: the M. D. Anderson experience. Cancer. 2000 Apr 15; 88(8):1837-41.
    View in: PubMed
    Score: 0.002
  326. Analysis of aromatic DNA adducts and 7,8-dihydro-8-oxo- 2'-deoxyguanosine in lymphocyte DNA from a case-control study of lung cancer involving minority populations. Mol Carcinog. 2000 Jan; 27(1):34-46.
    View in: PubMed
    Score: 0.002
  327. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. Oncogene. 1999 Dec 09; 18(52):7576-83.
    View in: PubMed
    Score: 0.002
  328. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 1999 Dec; 8(12):1071-8.
    View in: PubMed
    Score: 0.002
  329. Family history of cancer, mutagen sensitivity, and increased risk of head and neck cancer. Cancer Lett. 1999 Nov 01; 146(1):93-101.
    View in: PubMed
    Score: 0.002
  330. Ethnic differences in poly(ADP-ribose) polymerase pseudogene genotype distribution and association with lung cancer risk. Carcinogenesis. 1999 Aug; 20(8):1465-9.
    View in: PubMed
    Score: 0.002
  331. Glutathione-S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neck. Int J Cancer. 1999 Jun 21; 84(3):220-4.
    View in: PubMed
    Score: 0.002
  332. Three measures of mutagen sensitivity in a cancer-free population. Cancer Genet Cytogenet. 1999 Apr; 110(1):65-9.
    View in: PubMed
    Score: 0.002
  333. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst. 1999 Jan 20; 91(2):151-6.
    View in: PubMed
    Score: 0.002
  334. Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr Cancer. 1999; 33(1):20-5.
    View in: PubMed
    Score: 0.002
  335. Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer. 1998 Jul 15; 83(2):204-12.
    View in: PubMed
    Score: 0.002
  336. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck. Clin Cancer Res. 1998 Jul; 4(7):1773-8.
    View in: PubMed
    Score: 0.002
  337. Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 1998 Jul; 7(7):567-70.
    View in: PubMed
    Score: 0.002
  338. Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1998 Jun; 7(6):465-8.
    View in: PubMed
    Score: 0.002
  339. Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer. Cancer Epidemiol Biomarkers Prev. 1998 Apr; 7(4):309-14.
    View in: PubMed
    Score: 0.002
  340. Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's disease. Leuk Lymphoma. 1998 Feb; 28(5-6):561-6.
    View in: PubMed
    Score: 0.002
  341. Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States). Cancer Causes Control. 1997 Jul; 8(4):554-9.
    View in: PubMed
    Score: 0.001
  342. Evaluation of sister chromatid exchange and chromosome breaks in a cohort of untreated Hodgkin's disease patients. Cancer Epidemiol Biomarkers Prev. 1997 Apr; 6(4):291-3.
    View in: PubMed
    Score: 0.001
  343. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism. Cancer Epidemiol Biomarkers Prev. 1997 Feb; 6(2):87-92.
    View in: PubMed
    Score: 0.001
  344. Lung carcinoma in former smokers. Cancer. 1996 Sep 01; 78(5):1004-10.
    View in: PubMed
    Score: 0.001
  345. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. Cancer Res. 1996 Aug 15; 56(16):3638-41.
    View in: PubMed
    Score: 0.001
  346. Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia. Cancer Epidemiol Biomarkers Prev. 1996 Aug; 5(8):639-44.
    View in: PubMed
    Score: 0.001
  347. Fluorescent in situ hybridization analysis in blood lymphocytes of lung cancer patients. Anticancer Res. 1996 May-Jun; 16(3A):1187-92.
    View in: PubMed
    Score: 0.001
  348. Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst. 1996 Apr 17; 88(8):530-5.
    View in: PubMed
    Score: 0.001
  349. Sex chromosome abnormalities in lung cancer patients. Cancer Genet Cytogenet. 1996 Mar; 87(1):24-8.
    View in: PubMed
    Score: 0.001
  350. Glutathione s-transferase genotypes as risk factors for head and neck cancer. Am J Surg. 1995 Nov; 170(5):499-501.
    View in: PubMed
    Score: 0.001
  351. Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis. Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov; 4(7):743-9.
    View in: PubMed
    Score: 0.001
  352. p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res. 1995 Aug 15; 55(16):3604-9.
    View in: PubMed
    Score: 0.001
  353. Vasectomy and prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev. 1994 Jun; 3(4):285-8.
    View in: PubMed
    Score: 0.001
  354. Excess leukemia and multiple myeloma in a mining county in northeast Texas. Tex Med. 1994 Feb; 90(2):55-9.
    View in: PubMed
    Score: 0.001
  355. Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients. Cancer Epidemiol Biomarkers Prev. 1993 Mar-Apr; 2(2):103-6.
    View in: PubMed
    Score: 0.001
  356. Analysis of human papillomavirus DNA in oral squamous cell carcinomas. J Oral Pathol Med. 1993 Mar; 22(3):101-8.
    View in: PubMed
    Score: 0.001
  357. Mutagen sensitivity: a biological marker of cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1991 Nov-Dec; 1(1):83-9.
    View in: PubMed
    Score: 0.001
  358. Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. J Natl Cancer Inst. 1990 Nov 21; 82(22):1773-5.
    View in: PubMed
    Score: 0.001
  359. A case-control study of prostate cancer. Am J Epidemiol. 1989 Aug; 130(2):395-8.
    View in: PubMed
    Score: 0.001
  360. Cancer and age. Semin Oncol. 1989 Feb; 16(1):3-9.
    View in: PubMed
    Score: 0.001
  361. Season-of-birth and acute leukemia of infancy. Chronobiol Int. 1989; 6(3):285-9.
    View in: PubMed
    Score: 0.001
  362. Nitrite inhalants: historical perspective. NIDA Res Monogr. 1988; 83:1-14.
    View in: PubMed
    Score: 0.001
  363. Childhood nervous system tumors--an evaluation of the association with paternal occupational exposure to hydrocarbons. Am J Epidemiol. 1987 Oct; 126(4):605-13.
    View in: PubMed
    Score: 0.001
  364. Subfertility: an etiologic factor in development of testicular cancer? Urology. 1987 Sep; 30(3):199-200.
    View in: PubMed
    Score: 0.001
  365. Incidence of prostate cancer and marital status. J Natl Cancer Inst. 1987 Aug; 79(2):259-62.
    View in: PubMed
    Score: 0.001
  366. Incidence of testicular cancer in the United States related to marital status, histology, and ethnicity. J Natl Cancer Inst. 1987 May; 78(5):881-5.
    View in: PubMed
    Score: 0.001
  367. Epidemiologic similarities leading to etiologic hypotheses. Princess Takamatsu Symp. 1987; 18:173-80.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.